000			02035 a2200541 4500
005			20250514215709.0
264		0	_c20050714
008			200507s 0 0 eng d
022			_a0394-6320
024	7		_a10.1177/039463200501800109 _2doi
040			_aNLM _beng _cNLM
100	1		_aHritz, I
245	0	0	_aProton pump inhibitor co-therapy normalizes the increased cell turnover of the gastric mucosa both in NSAID and selective COX-2 users. _h[electronic resource]
260			_bInternational journal of immunopathology and pharmacology _c
300			_a75-84 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAnti-Inflammatory Agents, Non-Steroidal _xadverse effects
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aCell Count
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aCyclooxygenase 2
650	0	4	_aCyclooxygenase 2 Inhibitors
650	0	4	_aCyclooxygenase Inhibitors _xadverse effects
650	0	4	_aDNA Damage _xdrug effects
650	0	4	_aDouble-Blind Method
650	0	4	_aEnzyme Inhibitors _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aGastric Mucosa _xpathology
650	0	4	_aGenes, erbB-1 _xgenetics
650	0	4	_aGenes, p53 _xgenetics
650	0	4	_aHumans
650	0	4	_aImmunohistochemistry
650	0	4	_aIn Situ Nick-End Labeling
650	0	4	_aMale
650	0	4	_aMembrane Proteins
650	0	4	_aMiddle Aged
650	0	4	_aProliferating Cell Nuclear Antigen _xmetabolism
650	0	4	_aProstaglandin-Endoperoxide Synthases _xmetabolism
650	0	4	_aProton Pump Inhibitors
650	0	4	_aStomach Ulcer _xchemically induced
700	1		_aHerszenyi, L
700	1		_aMolnár, B
700	1		_aTulassay, Z
700	1		_aPrónai, L
773	0		_tInternational journal of immunopathology and pharmacology _gvol. 18 _gno. 1 _gp. 75-84
856	4	0	_uhttps://doi.org/10.1177/039463200501800109 _zAvailable from publisher's website
999			_c15375098 _d15375098